A 19-year-old male, on treatment for MDR-TB, presented with complaints of localized swelling over face, reddish discoloration of limbs, and hypopigmented patches over body since 1 month. He was on Category IV directly observed treatment, short-course chemotherapy for the last 5½ months on the basis of sputum line probe assay report from Revised National Tuberculosis Control Program (RNTCP) accredited laboratory, which showed M. tuberculosis isolates, resistant to drugs isoniazid and rifampicin. The patient was taking kanamycin, ethionamide, pyrazinamide, ethambutol, levofloxacin, and cycloserine regularly. There was a history of leprosy 6 years back, for which the patient was treated for 6 months. The patient had a history of TB 5 years back which was treated with 9 months of daily regimen antitubercular therapy. Clinical examination revealed hypopigmented, dry, scaly plaque over upper arms [], hypoanesthetic plaque over right palm [], and erythematous plaque over right side cheek and nose []. Respiratory system examination revealed bilateral infraclavicular crepts.\nRoutine investigations were normal. Chest radiograph was suggestive of fibrotic lesions, bilateral upper lobes []. Sputum culture from RNTCP accredited laboratory at 4th month was positive for growth of M. tuberculosis.\nDermatology review was taken for skin lesions. The patient was diagnosed as multibacillary (MB) leprosy and started on multidrug therapy regimen (MB-MDT) consisting of rifampicin 600 mg once monthly, dapsone 100 mg daily, and clofazimine 300 mg once monthly and 50 mg daily. Biopsy of skin lesions was suggestive of mid-borderline leprosy. Two weeks later, the patient presented with increased erythema and pain over the skin lesions and appearance of new lesions []. The patient was diagnosed with Type I lepra reaction and started on analgesics and steroids (prednisolone). Prednisolone was given in the dose of 30 mg/day orally for the first 2 weeks and then gradually tapered over the next 4 weeks. It was thus stopped after a total duration of 6 weeks. MB-MDT was continued as per the National Leprosy Eradication Programme guidelines.\nThus, final diagnosis of MDR-TB with mid-borderline leprosy and Type I lepra reaction was made. Skin lesions markedly improved with treatment []. Patient's subsequent sputum cultures were negative and MDR-TB was thereafter managed as per the RNTCP guidelines.
A 29-year-old male, born to nonconsanguineous parents, presented with multiple skin coloured nodules and hyperkeratotic scaly lesions of 3-month duration. He initially developed asymptomatic skin coloured raised lesions over both the ear lobes. Over the next 2 months he developed multiple similar lesions over the trunk and both the extremities. He also gave history of generalised burning sensation for 15-day duration with low grade fever. There was no history of burning sensation in the eyes, nasal stuffiness, and sensory or motor weakness. The patient denied any drug intake, fever, myalgia, spontaneous blistering or ulceration, neuritic pain, and testicular pain. None of the family members or neighbours had suffered from leprosy. He denied any past history of infectious diseases but there was no history of immunization including Bacillus Calmette et Guérin (BCG) vaccination. He was a chronic alcoholic.\nHis general physical examination was normal with no madarosis or lymphadenopathy. Cutaneous examination revealed multiple, soft, succulent, nontender, skin coloured superficial nodules present bilaterally on the forehead, cheeks, ear lobes, forearms, back, and chest with sparing of palms and soles (). The surface of these nodules showed follicular plugging. Multiple verrucous plaques were seen over the right ankle (). Skin surrounding the plaques was erythematous. Neurological examination revealed thickened bilateral greater auricular, right common peroneal nerve, and tender left posterior tibial nerve. The rest of the musculoskeletal and neurological examination was normal. Routine haematological and biochemical investigations including urine, renal, and liver function test revealed no abnormality. His retroviral serology was negative. Chest X-ray was normal. Slit skin smear from the lesion showed a bacteriological index (BI) of 5+ and the perilesional skin had a BI of 2+.\nHistopathological examination of the wedge biopsy done from the forearm and back nodules revealed sheets of histiocytes aggregates along with lymphocytes and few polymorphs in perivascular and periadnexal location (Figures and ). There was collection of epithelioid cells (). Fite Faraco stain was strongly positive (). A diagnosis of borderline lepromatous leprosy with type 2 reaction was made.\nA wedge biopsy from the verrucous lesion on the right ankle was taken. Epidermis showed hyperkeratosis and parakeratosis with irregular acanthosis (). Dermis showed epithelioid cell granulomas along with lymphocytes and plasma cells (Figures and ). Zeihl-Neelsen stain for acid fast bacilli was positive (). GeneXpert MTB/RIF test based on Nucleic Acid Amplification, which detects MTB-specific region of the rpoB gene and uses real time-PCR (RT-PCR), was done on skin biopsy specimen. The result was positive. However, a culture was not done. Based on clinical and histopathological findings, a diagnosis of tuberculosis verrucosa cutis (TVC) was made.\nThe patient was treated with rifampicin, isoniazid, pyrazinamide, and ethambutol, in addition to dapsone and clofazimine along with a monthly supervised dose of clofazimine and rifampicin for first 2 months. Then rifampicin and isoniazid with dapsone and clofazimine were continued for further 4 months. After 6 months, treatment of leprosy was continued as for multibacillary leprosy. Type 2 reaction was treated with oral anti-inflammatory drugs. The patient tolerated the drugs well with control of type 2 reaction and regression of the TVC lesion.